MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial
Active, not recruiting · NCT07505303 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 2 | 2026-06-25 | NCT07505303 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eccogene | 4 |
15 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.